Volume 23; Issue 9

Nature Biotechnology

Volume 23; Issue 9
1

King in the kingdom of uncertainty

Year:
2005
Language:
english
File:
PDF, 73 KB
english, 2005
2

Conflicting signals on US accelerated approvals

Year:
2005
Language:
english
File:
PDF, 220 KB
english, 2005
3

Europe caught in innovation quagmire

Year:
2005
Language:
english
File:
PDF, 56 KB
english, 2005
4

Mexico launches bold genome project

Year:
2005
Language:
english
File:
PDF, 121 KB
english, 2005
5

Materials exchange deal meager boost to India's biotech

Year:
2005
Language:
english
File:
PDF, 109 KB
english, 2005
6

News In Brief

Year:
2005
Language:
english
File:
PDF, 129 KB
english, 2005
7

Profile: Lisa Drakeman

Year:
2005
Language:
english
File:
PDF, 60 KB
english, 2005
8

R&D deals boom in 2004

Year:
2005
Language:
english
File:
PDF, 127 KB
english, 2005
9

The problem with potency

Year:
2005
Language:
english
File:
PDF, 135 KB
english, 2005
10

Problems with metagenomic screening

Year:
2005
Language:
english
File:
PDF, 112 KB
english, 2005
11

Reply to "Problems with metagenomic screening"

Year:
2005
Language:
english
File:
PDF, 190 KB
english, 2005
12

Open source and biotech

Year:
2005
Language:
english
File:
PDF, 130 KB
english, 2005
13

Empowering the inventor—the case of monoclonal antibodies

Year:
2005
Language:
english
File:
PDF, 95 KB
english, 2005
14

Overhauling oversight—European drug legislation

Year:
2005
Language:
english
File:
PDF, 182 KB
english, 2005
15

Flexibility—the guiding principle for antibody manufacturing

Year:
2005
Language:
english
File:
PDF, 1.15 MB
english, 2005
16

Rapid-response vaccines—does DNA offer a solution?

Year:
2005
Language:
english
File:
PDF, 190 KB
english, 2005
17

What a stock analyst can do for you

Year:
2005
Language:
english
File:
PDF, 56 KB
english, 2005
18

Upping the ante on antibodies

Year:
2005
Language:
english
File:
PDF, 204 KB
english, 2005
19

Monoclonal antibody successes in the clinic

Year:
2005
Language:
english
File:
PDF, 280 KB
english, 2005
20

The patentability of antibodies in the United States

Year:
2005
Language:
english
File:
PDF, 46 KB
english, 2005
21

Recent patent applications related to antibodies

Year:
2005
Language:
english
File:
PDF, 30 KB
english, 2005
22

The Lego-ization of polyketide biosynthesis

Year:
2005
Language:
english
File:
PDF, 170 KB
english, 2005
23

A farewell to bacterial ARMs?

Year:
2005
Language:
english
File:
PDF, 99 KB
english, 2005
24

Toward a universal multistrain bacterial vaccine

Year:
2005
Language:
english
File:
PDF, 78 KB
english, 2005
25

Protozoan genomics for drug discovery

Year:
2005
Language:
english
File:
PDF, 135 KB
english, 2005
26

Research Highlights

Year:
2005
Language:
english
File:
PDF, 88 KB
english, 2005
27

Are the current ontologies in biology good ontologies?

Year:
2005
Language:
english
File:
PDF, 246 KB
english, 2005
28

Liquid handling

Year:
2005
Language:
english
File:
PDF, 209 KB
english, 2005
29

Software

Year:
2005
Language:
english
File:
PDF, 209 KB
english, 2005
30

Biotech boom

Year:
2005
Language:
english
File:
PDF, 48 KB
english, 2005
31

People

Year:
2005
Language:
english
File:
PDF, 63 KB
english, 2005
32

Selecting and screening recombinant antibody libraries

Year:
2005
Language:
english
File:
PDF, 1.90 MB
english, 2005
36

Human antibodies from transgenic animals

Year:
2005
Language:
english
File:
PDF, 2.86 MB
english, 2005
37

Monoclonal antibody therapy of cancer

Year:
2005
Language:
english
File:
PDF, 4.78 MB
english, 2005
39

Arming antibodies: prospects and challenges for immunoconjugates

Year:
2005
Language:
english
File:
PDF, 1.15 MB
english, 2005
40

Engineered antibody fragments and the rise of single domains

Year:
2005
Language:
english
File:
PDF, 1.84 MB
english, 2005